M7T.ASX: Completion of On-Market Share Buy-Back

Completion of On-Market Share Buy-Back

Stock	MACH7 Technologies Ltd (M7T.ASX)
Release Time	4 Mar 2026, 9:29 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Mach7 Completes On-Market Share Buy-Back

Key Points

Mach7's on-market share buy-back program ended on 3 March 2026
6,273,000 shares were purchased for $2,236,019.43 at an average price of $0.3501
The buy-back program was announced on 30 January 2025

Full Summary

Mach7 Technologies Limited (ASX:M7T) has announced the completion of its on-market share buy-back program. The buy-back program was originally announced on 30 January 2025, with the Company stating it would purchase up to $5M of fully paid ordinary shares. The buy-back program ended on 3 March 2026, with a total of 6,273,000 shares purchased for $2,236,019.43 at an average price of $0.3501 per share. Further details of the completed buy-back program have been lodged with the ASX. Mach7 Technologies is a leading provider of medical imaging software, delivering advanced data management and diagnostic viewing solutions to healthcare organizations worldwide. The Company's Mach7 Enterprise Imaging Solution (EIS) is a next-generation solution combining a powerful Vendor Neutral Archive (VNA), the eUnity Enterprise Diagnostic Viewer, and robust diagnostic workflow applications.